早期乳酸清除率与心脏骤停后综合征患者预后改善相关:一项前瞻性多中心观察研究(SOS-KANTO 2012研究)
该研究为SOS-KANTO 2012前瞻性多中心观察性研究的事后分析,纳入日本关东地区67家急诊医院2012年1月至2013年3月收治的院外心脏骤停复苏后成人患者543例。入院时和入院6小时后测量血乳酸浓度,早期乳酸清除率定义为6小时后乳酸相对基线的百分比变化。平均乳酸清除率为42.4%±53.7%,总体30天生存率为47.1%,良好神经功能预后为27.4%。30天生存比例随乳酸清除率四分位升高而增加(Q1 29.4%、Q2 42.6%、Q3 51.5%、Q4 65.2%,p<0.001)。多因素logistic回归显示乳酸清除率四分位是30天生存和良好神经功能预后的独立预测因素;Cox比例风险模型显示Q1、Q2、Q3的30天死亡风险均显著高于Q4。
要点
- 院外心脏骤停复苏后成人患者中,30天生存比例随乳酸清除率四分位升高而增加:Q1 29.4%、Q2 42.6%、Q3 51.5%、Q4 65.2%(p<0.001)。
- 与乳酸清除率Q4相比,Q1的30天死亡风险HR为3.12(95%CI 2.14-4.53),Q2为2.13(95%CI 1.46-3.11),Q3为1.49(95%CI 1.01-2.19)。
- 多因素logistic回归分析显示,乳酸清除率四分位是30天生存和良好神经功能预后的独立预测因素。
- 多因素logistic回归分析显示,乳酸清除率是入院后30天良好神经功能预后的显著预测因素。
- 心脏骤停后最初6小时内有效的乳酸降低与生存和良好神经功能预后相关,且独立于初始乳酸水平。
适用人群与场景
- 日本关东地区67家急诊医院2012年1月至2013年3月收治的院外心脏骤停复苏成功后入院的成人患者。
诊断标准与关键阈值
- 早期乳酸清除率定义为入院6小时后乳酸水平相对入院基线测量值的百分比变化。
研究设计与关键结果
- 研究类型为前瞻性多中心观察性研究的事后分析,纳入543例患者(平均年龄65±16岁,男性72.6%),平均乳酸清除率42.4%±53.7%。
- 总体30天生存率为47.1%,良好神经功能预后为27.4%。
- 30天生存比例随乳酸清除率四分位升高而增加:Q1 29.4%、Q2 42.6%、Q3 51.5%、Q4 65.2%(p<0.001)。
- 多因素logistic回归分析显示乳酸清除率四分位是30天生存和良好神经功能预后的独立预测因素。
- Cox比例风险模型显示30天死亡频率:Q1 vs Q4 HR 3.12(95%CI 2.14-4.53),Q2 vs Q4 HR 2.13(95%CI 1.46-3.11),Q3 vs Q4 HR 1.49(95%CI 1.01-2.19)。
- 多因素logistic回归分析显示乳酸清除率是入院后30天良好神经功能预后的显著预测因素。
证据类型、等级与局限
- 证据类型:前瞻性多中心观察性研究的事后分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,心脏骤停后最初6小时内有效的乳酸降低与生存和良好神经功能预后相关,且独立于初始乳酸水平。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine whether early lactate reduction is associated with improved survival and good neurologic outcome in patients with out-of-hospital cardiac arrest.
DESIGN: Ad hoc data analysis of a prospective, multicenter observational study.
SETTING: Out-of-hospital cardiac arrest patients at 67 emergency hospitals in Kanto, Japan between January 2012 and March 2013.
PATIENTS: Adult patients with out-of-hospital cardiac arrest admitted to the hospital after successful resuscitation were identified.
INTERVENTIONS: Blood lactate concentrations were measured at hospital admission and 6 h after hospital admission. Early lactate clearance was defined as the percent change in lactate level 6 h after a baseline measurement.
MEASUREMENTS AND MAIN RESULTS: The 543 patients (mean age, 65 ± 16 yr; 72.6% male) had a mean lactate clearance of 42.4% ± 53.7%. Overall 30-day survival and good neurologic outcome were 47.1% and 27.4%, respectively. The survival proportion increased with increasing lactate clearance (quartile 1, 29.4%; quartile 2, 42.6%; quartile 3, 51.5%; quartile 4, 65.2%; p < 0.001). Multivariate logistic regression analysis showed that lactate clearance quartile was an independent predictor of the 30-day survival and good neurologic outcome. In the Cox proportional hazards model, the frequency of mortality during 30 days was significantly higher for patients with lactate clearance in quartile 1 (hazard ratio, 3.12; 95% CI, 2.14-4.53), quartile 2 (hazard ratio, 2.13; 95% CI, 1.46-3.11), and quartile 3 (hazard ratio, 1.49; 95% CI, 1.01-2.19) than those with lactate clearance in quartile 4. Furthermore, multivariate logistic regression analysis revealed that lactate clearance was a significant predictor of good neurologic outcome at 30 days after hospital admission.
CONCLUSIONS: Effective lactate reduction over the first 6 hours of postcardiac arrest care was associated with survival and good neurologic outcome independently of the initial lactate level.
参考来源
- Hayashida K, Suzuki M, Yonemoto N, et al. Early Lactate Clearance Is Associated With Improved Outcomes in Patients With Postcardiac Arrest Syndrome: A Prospective, Multicenter Observational Study (SOS-KANTO 2012 Study). Crit Care Med. 2017. PMID: 28328649. doi:10.1097/CCM.0000000000002307
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。